A Randomized Trial of Rofecoxib for the Chemoprevention of Colorectal Adenomas
Top Cited Papers
- 1 December 2006
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 131 (6) , 1674-1682
- https://doi.org/10.1053/j.gastro.2006.08.079
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- Epidemiology of Non-Steroidal Anti-Inflammatory Drugs and CancerPublished by S. Karger AG ,2003
- Back to an Aspirin a Day?Science, 2002
- COX-2: A Target for Colon Cancer PreventionAnnual Review of Pharmacology and Toxicology, 2002
- Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical IssuesJNCI Journal of the National Cancer Institute, 2002
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)Cell, 1996
- Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 ratsCarcinogenesis: Integrative Cancer Research, 1993